Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colin Ard

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Power calculations for clinical trials in Alzheimer's diseaseM Colin Ard, Steven D Edland
International Journal of Statistics in Medical Research|January 25, 2021
Power Calculations for Two-Wave, Change from Baseline to Follow-up Study DesignsM Colin Ard, Steven D Edland
Pharmaceutical Statistics|July 31, 2015
Optimal composite scores for longitudinal clinical trials under the linear mixed effects modelM Colin Ard, Nandini Raghavan, Steven D Edland
Pharmaceutical Statistics|March 10, 2020
Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18 (2):239-47, 2019, DOI: 10.1002/pst.1920Steven D Edland, Nandini Raghavan, M Colin Ard
Alzheimer Disease and Associated Disorders|August 10, 2012
Improved statistical power of Alzheimer clinical trials by item-response theory: proof of concept by application to the activities of daily living scaleM Colin Ard, Douglas R Galasko, Steven D Edland
Alzheimer'S & Dementia (New York, N. Y.)|September 19, 2017
Design of pilot studies to inform the construction of composite outcome measuresSteven D Edland, M Colin Ard, Weiwei Li, et al.
Journal of Experimental Psychology. Learning, Memory, and Cognition|July 9, 2008
Sleep does not enhance motor sequence learningTimothy C Rickard, Denise J Cai, Cory A Rieth, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
Potential implications of practice effects in Alzheimer's disease prevention trialsDiane M Jacobs, M Colin Ard, David P Salmon, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 28, 2017
Proof of concept demonstration of optimal composite MRI endpoints for clinical trialsSteven D Edland, M Colin Ard, Jaiashre Sridhar, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 4, 2018
Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI studyEmily C Edmonds, M Colin Ard, Steven D Edland, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Power calculations for clinical trials in Alzheimer's diseaseM Colin Ard, Steven D Edland
International Journal of Statistics in Medical Research|January 25, 2021
Power Calculations for Two-Wave, Change from Baseline to Follow-up Study DesignsM Colin Ard, Steven D Edland
Pharmaceutical Statistics|July 31, 2015
Optimal composite scores for longitudinal clinical trials under the linear mixed effects modelM Colin Ard, Nandini Raghavan, Steven D Edland
Pharmaceutical Statistics|March 10, 2020
Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18 (2):239-47, 2019, DOI: 10.1002/pst.1920Steven D Edland, Nandini Raghavan, M Colin Ard
Alzheimer Disease and Associated Disorders|August 10, 2012
Improved statistical power of Alzheimer clinical trials by item-response theory: proof of concept by application to the activities of daily living scaleM Colin Ard, Douglas R Galasko, Steven D Edland
Alzheimer'S & Dementia (New York, N. Y.)|September 19, 2017
Design of pilot studies to inform the construction of composite outcome measuresSteven D Edland, M Colin Ard, Weiwei Li, et al.
Journal of Experimental Psychology. Learning, Memory, and Cognition|July 9, 2008
Sleep does not enhance motor sequence learningTimothy C Rickard, Denise J Cai, Cory A Rieth, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
Potential implications of practice effects in Alzheimer's disease prevention trialsDiane M Jacobs, M Colin Ard, David P Salmon, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 28, 2017
Proof of concept demonstration of optimal composite MRI endpoints for clinical trialsSteven D Edland, M Colin Ard, Jaiashre Sridhar, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 4, 2018
Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI studyEmily C Edmonds, M Colin Ard, Steven D Edland, et al.
Pageof 2